UCLA HRPP Guidance, Procedures, and Policies


The text of any Federal regulation cited in these policies may be found using the Electronic Code of Federal Regulations (e-CFR).

The text of any California law cited in these policies may be found using the Official California Legislative Information website.


UCLA OHRPP/IRB Policies

The IRB/OHRPP Policy Compilation (a 3 Mb searchable PDF file) includes all the individual policies listed below. - Temporarily Unavailable


#TitleLast Revised
1 UCLA Policy 991: Protection of Human Subjects in Research January 23, 2009
2 Determining Which Research Activities Require UCLA OHRPP/IRB Review January 27, 2009
4 Research Conducted by UCLA Students February 26, 2009
5 OPRS Review Process - Certification of Exemption from IRB Review February 26, 2009
6 IRB Review Process - Initial Review February 26, 2009
7 Materials Required for IRB Review April 14, 2009
8 IRB Review Process - Expedited Review March 5, 2009
9 IRB Review Process - Full Committee Review July 5, 2007
10 IRB Review Process - Continuing Review February 26, 2009
11 IRB Review of Modifications to Previously Approved Research July 5, 2007
12 IRB Review Process - Communication of IRB Actions February 26, 2009
13 Referral to the IRB Executive Committee February 26, 2009
15 Biomedical Adverse Event Reporting
Please refer to HRPP Guidance & Procedure 57
 
16 IRB Process - Consultant Review July 5, 2007
17 Closure of Human Subjects Research Studies April 27, 2009
18 Approvals From Other UCLA and External Committees February 26, 2009
20 Special Considerations for Projects Involving Vulnerable Populations February 26, 2009
21 Special Subject Populations: Children February 26, 2009
22 Special Subject Populations: Pregnant Women, Human Fetuses, and Neonates July 5, 2007
23 Special Subject Populations: Prisoners July 5, 2007
24 Special Subject Populations: Cognitively Impaired July 5, 2007
25 Special Subject Populations: Students and Employees March 5, 2009
26 Special Subject Populations: Non-English Speaking Subjects March 6, 2009
27 Third Party Subjects (a.k.a., Secondary Subjects) July 5, 2007
28 Subject Pools and Recruitment Databases March 6, 2009
29 Informed Consent Process and Documentation February 26, 2009
29a The Use of Legally Authorized Representatives or Surrogate Consent February 26, 2009
30 Recruitment Methods & Tools July 5, 2007
31 Payment for Participation in Research July 5, 2007
32 Financial Obligations July 5, 2007
33 Emergency Care and Compensation for Injury July 5, 2007
34 FDA Requirements February 11, 2008
35 IRB Approved Research in an Emergency Setting February 11, 2008
36 Emergency Use of a Test Article May 14, 2009
37 Genetics Research April 14, 2009
38 Human Embryonic Stem Cell Research July 5, 2007
39 Research Collection, Use, and Secondary Analysis of Human Specimens and/or Data April 13, 2009
40 Data and Specimen Repositories April 13, 2009
41 Data Safety Monitoring Plan April 10, 2009
42 Research Involving Public Use Data Files March 5, 2009
43 Data Security in Research April 8, 2009
44 Research Involving the Internet July 5, 2007
45 Research Involving Multiple Performance Sites or Collaborating Agencies or Institutions February 11, 2008
46 Research Conducted in International Settings July 5, 2007
47 Family Educational Rights and Privacy Act (FERPA) July 5, 2007
48 Protection of Pupil Rights Amendment (PPRA) July 5, 2007
49 Health Insurance Portability and Accountability Act (HIPAA) July 5, 2007
51 Reporting Suspected Abuse of Children, Elderly Individuals, and Others July 5, 2007
52 Reporting of Diseases and Conditions Identified in the Course of Research July 5, 2007
53 Noncompliance and Allegations of Noncompliance Regarding the Conduct of Human Subjects Research January 27, 2009
54 Consent Monitoring July 5, 2007
55 On Site Reviews of Human Research Studies November 12, 2009
56 HRPP Quality Improvement Activities April 14, 2009
57 Post-Approval Reporting Requirements for Investigators: Reporting of Unanticipated Problems, Including Adverse Events as well as Protocol Violations, Deviations and Incidents and the Reporting of Updated Study Safety Information May 13, 2009
58 Complaints and Concerns Regarding the Conduct of Human Subjects Research February 26, 2009
59 Suspension and Termination of Research February 26, 2009
60 Reporting Procedures For Unanticipated Problems, Noncompliance, Suspension, or Termination February 26, 2009
61 Investigator Responsibilities April 7, 2009
63 Investigator Financial Interests and Conflicts of Interest July 5, 2007
64 HRPP Education and Training April 7, 2009
65 IRB Membership March 6, 2009
67 IRB Member Conflict of Interest July 5, 2007
69 IRB Meeting and Minutes February 26, 2009
70 IRB Office Records February 26, 2009
71 Media Interviews July 5, 2007


UCLA OHRPP/IRB Guidance

TopicLast Revised
Human Embryonic Stem Cell Research and IRB Review Jan 05, 2007
Certificate of Confidentiality August 4, 2008
Disclosure of Possible Conflict of Interest to Human Research Subjects April 20, 1999
Emergency Care and Compensation for Injury March 16, 2006
Fees for Reviews of Industry-Sponsored Clinical Trials 2002
Gift Policy and Human Subjects Research April 6, 2004
HIPAA May 2005
HIV Reporting July 6, 2006
Navy-Supported Research June 6, 2007
Oral History December 10, 2003
Screening Research Subjects October 7, 2001
Suicide Risk and Research Protocols May 26, 2006
UCLA/RAND Memorandum of Understanding August 29, 2006